Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 87 entries
Sorted by: Best Match Show Resources per page
Complex Langevin simulations of non-Abelian integrals.

Physical review. D, Particles and fields

Haymaker RW, Wosiek J.
PMID: 9958765
Phys Rev D Part Fields. 1988 Feb 15;37(4):969-973. doi: 10.1103/physrevd.37.969.

No abstract available.

Cite
Haymaker RW, Wosiek J. Complex Langevin simulations of non-Abelian integrals. Phys Rev D Part Fields. 1988;37(4):969-973doi: 10.1103/physrevd.37.969.
Haymaker, R. W., & Wosiek, J. (1988). Complex Langevin simulations of non-Abelian integrals. Physical review. D, Particles and fields, 37(4), 969-973. https://doi.org/10.1103/physrevd.37.969
Haymaker, and Wosiek. "Complex Langevin simulations of non-Abelian integrals." Physical review. D, Particles and fields vol. 37,4 (1988): 969-973. doi: https://doi.org/10.1103/physrevd.37.969
Haymaker RW, Wosiek J. Complex Langevin simulations of non-Abelian integrals. Phys Rev D Part Fields. 1988 Feb 15;37(4):969-973. doi: 10.1103/physrevd.37.969. PMID: 9958765.
Copy Download .nbib Format: NLM
Disappearance of the Abrikosov vortex above the deconfining phase transition in SU(2) lattice gauge theory.

Physical review. D, Particles and fields

Haymaker RW, Peng Y.
PMID: 10019517
Phys Rev D Part Fields. 1995 Sep 01;52(5):3030-3035. doi: 10.1103/physrevd.52.3030.

No abstract available.

Cite
Haymaker RW, Peng Y. Disappearance of the Abrikosov vortex above the deconfining phase transition in SU(2) lattice gauge theory. Phys Rev D Part Fields. 1995;52(5):3030-3035doi: 10.1103/physrevd.52.3030.
Haymaker, R. W., & Peng, Y. (1995). Disappearance of the Abrikosov vortex above the deconfining phase transition in SU(2) lattice gauge theory. Physical review. D, Particles and fields, 52(5), 3030-3035. https://doi.org/10.1103/physrevd.52.3030
Haymaker, and Peng. "Disappearance of the Abrikosov vortex above the deconfining phase transition in SU(2) lattice gauge theory." Physical review. D, Particles and fields vol. 52,5 (1995): 3030-3035. doi: https://doi.org/10.1103/physrevd.52.3030
Haymaker RW, Peng Y. Disappearance of the Abrikosov vortex above the deconfining phase transition in SU(2) lattice gauge theory. Phys Rev D Part Fields. 1995 Sep 01;52(5):3030-3035. doi: 10.1103/physrevd.52.3030. PMID: 10019517.
Copy Download .nbib Format: NLM
Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic.

The British journal of dermatology

van Winden MEC, Klösters FM, Hamaker M, Olde Rikkert MG, van de Kerkhof PCM, de Jong EMGJ, Lubeek SFK.
PMID: 34698375
Br J Dermatol. 2021 Oct 26; doi: 10.1111/bjd.20833. Epub 2021 Oct 26.

No abstract available.

Cite
van Winden MEC, Klösters FM, Hamaker M, et al. Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic. Br J Dermatol. 2021;doi: 10.1111/bjd.20833.
van Winden, M. E. C., Klösters, F. M., Hamaker, M., Olde Rikkert, M. G., van de Kerkhof, P. C. M., de Jong, E. M. G. J., & Lubeek, S. F. K. (2021). Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic. The British journal of dermatology, . https://doi.org/10.1111/bjd.20833
van Winden, M E C, et al. "Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic." The British journal of dermatology vol. (2021). doi: https://doi.org/10.1111/bjd.20833
van Winden MEC, Klösters FM, Hamaker M, Olde Rikkert MG, van de Kerkhof PCM, de Jong EMGJ, Lubeek SFK. Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic. Br J Dermatol. 2021 Oct 26; doi: 10.1111/bjd.20833. Epub 2021 Oct 26. PMID: 34698375.
Copy Download .nbib Format: NLM
Levels of Salmonella enterica and Listeria monocytogenes in Alternative Irrigation Water Vary Based on Water Source on the Eastern Shore of Maryland.

Microbiology spectrum

Acheamfour CL, Parveen S, Hashem F, Sharma M, Gerdes ME, May EB, Rogers K, Haymaker J, Duncan R, Foust D, Taabodi M, Handy ET, East C, Bradshaw R, Kim S, Micallef SA, Callahan MT, Allard S, Anderson-Coughlin B, Craighead S, Gartley S, Vanore A, Kniel KE, Solaiman S, Bui A, Murray R, Craddock HA, Kulkarni P, Rosenberg Goldstein RE, Sapkota AR.
PMID: 34612697
Microbiol Spectr. 2021 Oct 31;9(2):e0066921. doi: 10.1128/Spectrum.00669-21. Epub 2021 Oct 06.

Irrigation water sources have been shown to harbor foodborne pathogens and could contribute to the outbreak of foodborne illness related to consumption of contaminated produce. Determining the probability of and the degree to which these irrigation water sources contain...

Cite
Acheamfour CL, Parveen S, Hashem F, et al. Levels of Salmonella enterica and Listeria monocytogenes in Alternative Irrigation Water Vary Based on Water Source on the Eastern Shore of Maryland. Microbiol Spectr. 2021;9(2):e0066921doi: 10.1128/Spectrum.00669-21.
Acheamfour, C. L., Parveen, S., Hashem, F., Sharma, M., Gerdes, M. E., May, E. B., Rogers, K., Haymaker, J., Duncan, R., Foust, D., Taabodi, M., Handy, E. T., East, C., Bradshaw, R., Kim, S., Micallef, S. A., Callahan, M. T., Allard, S., Anderson-Coughlin, B., Craighead, S., Gartley, S., Vanore, A., Kniel, K. E., Solaiman, S., Bui, A., Murray, R., Craddock, H. A., Kulkarni, P., Rosenberg Goldstein, R. E., & Sapkota, A. R. (2021). Levels of Salmonella enterica and Listeria monocytogenes in Alternative Irrigation Water Vary Based on Water Source on the Eastern Shore of Maryland. Microbiology spectrum, 9(2), e0066921. https://doi.org/10.1128/Spectrum.00669-21
Acheamfour, Chanelle L, et al. "Levels of Salmonella enterica and Listeria monocytogenes in Alternative Irrigation Water Vary Based on Water Source on the Eastern Shore of Maryland." Microbiology spectrum vol. 9,2 (2021): e0066921. doi: https://doi.org/10.1128/Spectrum.00669-21
Acheamfour CL, Parveen S, Hashem F, Sharma M, Gerdes ME, May EB, Rogers K, Haymaker J, Duncan R, Foust D, Taabodi M, Handy ET, East C, Bradshaw R, Kim S, Micallef SA, Callahan MT, Allard S, Anderson-Coughlin B, Craighead S, Gartley S, Vanore A, Kniel KE, Solaiman S, Bui A, Murray R, Craddock HA, Kulkarni P, Rosenberg Goldstein RE, Sapkota AR. Levels of Salmonella enterica and Listeria monocytogenes in Alternative Irrigation Water Vary Based on Water Source on the Eastern Shore of Maryland. Microbiol Spectr. 2021 Oct 31;9(2):e0066921. doi: 10.1128/Spectrum.00669-21. Epub 2021 Oct 06. PMID: 34612697; PMCID: PMC8510256.
Copy Download .nbib Format: NLM
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.

Journal for immunotherapy of cancer

Saberian C, Amaria RN, Najjar AM, Radvanyi LG, Haymaker CL, Forget MA, Bassett RL, Faria SC, Glitza IC, Alvarez E, Parshottam S, Prieto V, Lizée G, Wong MK, McQuade JL, Diab A, Yee C, Tawbi HA, Patel S, Shpall EJ, Davies MA, Hwu P, Bernatchez C.
PMID: 34021033
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2021-002449.

BACKGROUND: The adoptive transfer of tumor-infiltrating lymphocytes (TIL) has demonstrated robust efficacy in metastatic melanoma patients. Tumor antigen-loaded dendritic cells (DCs) are believed to optimally activate antigen-specific T lymphocytes. We hypothesized that the combined transfer of TIL, containing a...

Cite
Saberian C, Amaria RN, Najjar AM, et al. Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. J Immunother Cancer. 2021;9(5)doi: 10.1136/jitc-2021-002449.
Saberian, C., Amaria, R. N., Najjar, A. M., Radvanyi, L. G., Haymaker, C. L., Forget, M. A., Bassett, R. L., Faria, S. C., Glitza, I. C., Alvarez, E., Parshottam, S., Prieto, V., Lizée, G., Wong, M. K., McQuade, J. L., Diab, A., Yee, C., Tawbi, H. A., Patel, S., Shpall, E. J., Davies, M. A., Hwu, P., & Bernatchez, C. (2021). Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. Journal for immunotherapy of cancer, 9(5), . https://doi.org/10.1136/jitc-2021-002449
Saberian, Chantal, et al. "Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma." Journal for immunotherapy of cancer vol. 9,5 (2021). doi: https://doi.org/10.1136/jitc-2021-002449
Saberian C, Amaria RN, Najjar AM, Radvanyi LG, Haymaker CL, Forget MA, Bassett RL, Faria SC, Glitza IC, Alvarez E, Parshottam S, Prieto V, Lizée G, Wong MK, McQuade JL, Diab A, Yee C, Tawbi HA, Patel S, Shpall EJ, Davies MA, Hwu P, Bernatchez C. Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2021-002449. PMID: 34021033; PMCID: PMC8144048.
Copy Download .nbib Format: NLM
Loss of Rnf43 accelerates Kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma.

Gastroenterology

Hosein AN, Dangol G, Okumura T, Roszik J, Rajapakshe K, Siemann M, Zaid M, Ghosh B, Monberg M, Guerrero PA, Singhi A, Haymaker CL, Clevers H, Abou-Elkacem L, Woermann SM, Maitra A.
PMID: 34973294
Gastroenterology. 2021 Dec 29; doi: 10.1053/j.gastro.2021.12.273. Epub 2021 Dec 29.

BACKGROUND: RNF43 is an E3 ubiquitin ligase that is recurrently mutated in pancreatic ductal adenocarcinoma (PDAC) and precursor cystic neoplasms of the pancreas. The impact of RNF43 mutations on PDAC is poorly understood and autochthonous models have not been...

Cite
Hosein AN, Dangol G, Okumura T, et al. Loss of Rnf43 accelerates Kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma. Gastroenterology. 2021;doi: 10.1053/j.gastro.2021.12.273.
Hosein, A. N., Dangol, G., Okumura, T., Roszik, J., Rajapakshe, K., Siemann, M., Zaid, M., Ghosh, B., Monberg, M., Guerrero, P. A., Singhi, A., Haymaker, C. L., Clevers, H., Abou-Elkacem, L., Woermann, S. M., & Maitra, A. (2021). Loss of Rnf43 accelerates Kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma. Gastroenterology, . https://doi.org/10.1053/j.gastro.2021.12.273
Hosein, Abdel Nasser, et al. "Loss of Rnf43 accelerates Kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma." Gastroenterology vol. (2021). doi: https://doi.org/10.1053/j.gastro.2021.12.273
Hosein AN, Dangol G, Okumura T, Roszik J, Rajapakshe K, Siemann M, Zaid M, Ghosh B, Monberg M, Guerrero PA, Singhi A, Haymaker CL, Clevers H, Abou-Elkacem L, Woermann SM, Maitra A. Loss of Rnf43 accelerates Kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma. Gastroenterology. 2021 Dec 29; doi: 10.1053/j.gastro.2021.12.273. Epub 2021 Dec 29. PMID: 34973294.
Copy Download .nbib Format: NLM
Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC.

Clinical cancer research : an official journal of the American Association for Cancer Research

Sahaf B, Pichavant M, Lee BH, Duault C, Thrash EM, Davila M, Fernandez N, Millerchip K, Bentebibel SE, Haymaker C, Sigal N, Del Valle DM, Ranasinghe S, Fayle S, Sanchez-Espiridion B, Zhang J, Bernatchez C, Wu CJ, Wistuba II, Kim-Schulze S, Gnjatic S, Bendall SC, Song M, Thurin M, Lee JJ, Maecker HT, Rahman A.
PMID: 34266889
Clin Cancer Res. 2021 Sep 15;27(18):5062-5071. doi: 10.1158/1078-0432.CCR-21-2052. Epub 2021 Jul 15.

PURPOSE: The Cancer Immune Monitoring and Analysis Centers - Cancer Immunologic Data Commons (CIMAC-CIDC) Network is supported by the NCI to identify biomarkers of response to cancer immunotherapies across clinical trials using state-of-the-art assays. A primary platform for CIMAC-CIDC...

Cite
Sahaf B, Pichavant M, Lee BH, et al. Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC. Clin Cancer Res. 2021;27(18):5062-5071doi: 10.1158/1078-0432.CCR-21-2052.
Sahaf, B., Pichavant, M., Lee, B. H., Duault, C., Thrash, E. M., Davila, M., Fernandez, N., Millerchip, K., Bentebibel, S. E., Haymaker, C., Sigal, N., Del Valle, D. M., Ranasinghe, S., Fayle, S., Sanchez-Espiridion, B., Zhang, J., Bernatchez, C., Wu, C. J., Wistuba, I. I., Kim-Schulze, S., Gnjatic, S., Bendall, S. C., Song, M., Thurin, M., Lee, J. J., Maecker, H. T., & Rahman, A. (2021). Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(18), 5062-5071. https://doi.org/10.1158/1078-0432.CCR-21-2052
Sahaf, Bita, et al. "Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,18 (2021): 5062-5071. doi: https://doi.org/10.1158/1078-0432.CCR-21-2052
Sahaf B, Pichavant M, Lee BH, Duault C, Thrash EM, Davila M, Fernandez N, Millerchip K, Bentebibel SE, Haymaker C, Sigal N, Del Valle DM, Ranasinghe S, Fayle S, Sanchez-Espiridion B, Zhang J, Bernatchez C, Wu CJ, Wistuba II, Kim-Schulze S, Gnjatic S, Bendall SC, Song M, Thurin M, Lee JJ, Maecker HT, Rahman A. Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC. Clin Cancer Res. 2021 Sep 15;27(18):5062-5071. doi: 10.1158/1078-0432.CCR-21-2052. Epub 2021 Jul 15. PMID: 34266889; PMCID: PMC8448982.
Copy Download .nbib Format: NLM
Next-Generation Immunotherapies to Improve Anticancer Immunity.

Frontiers in pharmacology

Shi Y, Tomczak K, Li J, Ochieng JK, Lee Y, Haymaker C.
PMID: 33505304
Front Pharmacol. 2021 Jan 11;11:566401. doi: 10.3389/fphar.2020.566401. eCollection 2020.

Checkpoint inhibitors are widely used immunotherapies for advanced cancer. Nonetheless, checkpoint inhibitors have a relatively low response rate, work in a limited range of cancers, and have some unignorable side effects. Checkpoint inhibitors aim to reinvigorate exhausted or suppressed...

Cite
Shi Y, Tomczak K, Li J, et al. Next-Generation Immunotherapies to Improve Anticancer Immunity. Front Pharmacol. 2021;11:566401doi: 10.3389/fphar.2020.566401.
Shi, Y., Tomczak, K., Li, J., Ochieng, J. K., Lee, Y., & Haymaker, C. (2020). Next-Generation Immunotherapies to Improve Anticancer Immunity. Frontiers in pharmacology, 11566401. https://doi.org/10.3389/fphar.2020.566401
Shi, Yaoyao, et al. "Next-Generation Immunotherapies to Improve Anticancer Immunity." Frontiers in pharmacology vol. 11 (2020): 566401. doi: https://doi.org/10.3389/fphar.2020.566401
Shi Y, Tomczak K, Li J, Ochieng JK, Lee Y, Haymaker C. Next-Generation Immunotherapies to Improve Anticancer Immunity. Front Pharmacol. 2021 Jan 11;11:566401. doi: 10.3389/fphar.2020.566401. eCollection 2020. PMID: 33505304; PMCID: PMC7831045.
Copy Download .nbib Format: NLM
COVID-19 and Loneliness among Older Adults: Associations with Mode of Family/Friend Contacts and Social Participation.

Clinical gerontologist

Choi NG, Hammaker S, DiNitto DM, Marti CN.
PMID: 34962454
Clin Gerontol. 2021 Dec 28;1-13. doi: 10.1080/07317115.2021.2013383. Epub 2021 Dec 28.

OBJECTIVES: Given physical/social distancing due to COVID-19, we examined associations between self-reported loneliness and changes in contact with family/friends and mode of social participation among older adults.METHODS: Data came from the 2020 National Health and Aging Trend Study (NHATS)...

Cite
Choi NG, Hammaker S, DiNitto DM, et al. COVID-19 and Loneliness among Older Adults: Associations with Mode of Family/Friend Contacts and Social Participation. Clin Gerontol. 2021;1-13doi: 10.1080/07317115.2021.2013383.
Choi, N. G., Hammaker, S., DiNitto, D. M., & Marti, C. N. (2021). COVID-19 and Loneliness among Older Adults: Associations with Mode of Family/Friend Contacts and Social Participation. Clinical gerontologist, 1-13. https://doi.org/10.1080/07317115.2021.2013383
Choi, Namkee G, et al. "COVID-19 and Loneliness among Older Adults: Associations with Mode of Family/Friend Contacts and Social Participation." Clinical gerontologist vol. (2021): 1-13. doi: https://doi.org/10.1080/07317115.2021.2013383
Choi NG, Hammaker S, DiNitto DM, Marti CN. COVID-19 and Loneliness among Older Adults: Associations with Mode of Family/Friend Contacts and Social Participation. Clin Gerontol. 2021 Dec 28;1-13. doi: 10.1080/07317115.2021.2013383. Epub 2021 Dec 28. PMID: 34962454.
Copy Download .nbib Format: NLM
Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma.

Cancer discovery

Haymaker C, Johnson DH, Murthy R, Bentebibel SE, Uemura MI, Hudgens CW, Safa H, James M, Andtbacka RHI, Johnson DB, Shaheen M, Davies MA, Rahimian S, Chunduru SK, Milton DR, Tetzlaff MT, Overwijk WW, Hwu P, Gabrail N, Agrawal S, Doolittle G, Puzanov I, Markowitz J, Bernatchez C, Diab A.
PMID: 33707233
Cancer Discov. 2021 Aug;11(8):1996-2013. doi: 10.1158/2159-8290.CD-20-1546. Epub 2021 Mar 11.

Many patients with advanced melanoma are resistant to immune checkpoint inhibition. In the ILLUMINATE-204 phase I/II trial, we assessed intratumoral tilsotolimod, an investigational Toll-like receptor 9 agonist, with systemic ipilimumab in patients with anti-PD-1- resistant advanced melanoma. In all...

Cite
Haymaker C, Johnson DH, Murthy R, et al. Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma. Cancer Discov. 2021;11(8):1996-2013doi: 10.1158/2159-8290.CD-20-1546.
Haymaker, C., Johnson, D. H., Murthy, R., Bentebibel, S. E., Uemura, M. I., Hudgens, C. W., Safa, H., James, M., Andtbacka, R. H. I., Johnson, D. B., Shaheen, M., Davies, M. A., Rahimian, S., Chunduru, S. K., Milton, D. R., Tetzlaff, M. T., Overwijk, W. W., Hwu, P., Gabrail, N., Agrawal, S., Doolittle, G., Puzanov, I., Markowitz, J., Bernatchez, C., & Diab, A. (2021). Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma. Cancer discovery, 11(8), 1996-2013. https://doi.org/10.1158/2159-8290.CD-20-1546
Haymaker, Cara, et al. "Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma." Cancer discovery vol. 11,8 (2021): 1996-2013. doi: https://doi.org/10.1158/2159-8290.CD-20-1546
Haymaker C, Johnson DH, Murthy R, Bentebibel SE, Uemura MI, Hudgens CW, Safa H, James M, Andtbacka RHI, Johnson DB, Shaheen M, Davies MA, Rahimian S, Chunduru SK, Milton DR, Tetzlaff MT, Overwijk WW, Hwu P, Gabrail N, Agrawal S, Doolittle G, Puzanov I, Markowitz J, Bernatchez C, Diab A. Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma. Cancer Discov. 2021 Aug;11(8):1996-2013. doi: 10.1158/2159-8290.CD-20-1546. Epub 2021 Mar 11. PMID: 33707233; PMCID: PMC8544022.
Copy Download .nbib Format: NLM
Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies.

Clinical cancer research : an official journal of the American Association for Cancer Research

Lee JJ, Bernard V, Semaan A, Monberg ME, Huang J, Stephens BM, Lin D, Rajapakshe KI, Weston BR, Bhutani MS, Haymaker CL, Bernatchez C, Taniguchi CM, Maitra A, Guerrero PA.
PMID: 34426439
Clin Cancer Res. 2021 Nov 01;27(21):5912-5921. doi: 10.1158/1078-0432.CCR-20-3925. Epub 2021 Aug 23.

PURPOSE: Precision medicine approaches in pancreatic ductal adenocarcinoma (PDAC) are imperative for improving disease outcomes. With molecular subtypes of PDAC gaining relevance in the context of therapeutic stratification, the ability to characterize heterogeneity of cancer-specific gene expression patterns is...

Cite
Lee JJ, Bernard V, Semaan A, et al. Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies. Clin Cancer Res. 2021;27(21):5912-5921doi: 10.1158/1078-0432.CCR-20-3925.
Lee, J. J., Bernard, V., Semaan, A., Monberg, M. E., Huang, J., Stephens, B. M., Lin, D., Rajapakshe, K. I., Weston, B. R., Bhutani, M. S., Haymaker, C. L., Bernatchez, C., Taniguchi, C. M., Maitra, A., & Guerrero, P. A. (2021). Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(21), 5912-5921. https://doi.org/10.1158/1078-0432.CCR-20-3925
Lee, Jaewon J, et al. "Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,21 (2021): 5912-5921. doi: https://doi.org/10.1158/1078-0432.CCR-20-3925
Lee JJ, Bernard V, Semaan A, Monberg ME, Huang J, Stephens BM, Lin D, Rajapakshe KI, Weston BR, Bhutani MS, Haymaker CL, Bernatchez C, Taniguchi CM, Maitra A, Guerrero PA. Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies. Clin Cancer Res. 2021 Nov 01;27(21):5912-5921. doi: 10.1158/1078-0432.CCR-20-3925. Epub 2021 Aug 23. PMID: 34426439; PMCID: PMC8563410.
Copy Download .nbib Format: NLM
Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma.

The Annals of thoracic surgery

Zhou N, Rice DC, Tsao AS, Lee PP, Haymaker CL, Corsini EM, Antonoff MB, Hofstetter WL, Rajaram R, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ, Sepesi B.
PMID: 33971174
Ann Thorac Surg. 2022 Jan;113(1):200-208. doi: 10.1016/j.athoracsur.2021.04.078. Epub 2021 May 08.

BACKGROUND: Whether extrapleural pneumonectomy (EPP) or extended pleurectomy/decortication (P/D) is the optimal resection for malignant pleural mesothelioma remains controversial. We therefore compared perioperative outcomes and long-term survival of patients who underwent EPP versus P/D.METHODS: Patients with the diagnosis of...

Cite
Zhou N, Rice DC, Tsao AS, et al. Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma. Ann Thorac Surg. 2021;113(1):200-208doi: 10.1016/j.athoracsur.2021.04.078.
Zhou, N., Rice, D. C., Tsao, A. S., Lee, P. P., Haymaker, C. L., Corsini, E. M., Antonoff, M. B., Hofstetter, W. L., Rajaram, R., Roth, J. A., Swisher, S. G., Vaporciyan, A. A., Walsh, G. L., Mehran, R. J., & Sepesi, B. (2022). Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma. The Annals of thoracic surgery, 113(1), 200-208. https://doi.org/10.1016/j.athoracsur.2021.04.078
Zhou, Nicolas, et al. "Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma." The Annals of thoracic surgery vol. 113,1 (2022): 200-208. doi: https://doi.org/10.1016/j.athoracsur.2021.04.078
Zhou N, Rice DC, Tsao AS, Lee PP, Haymaker CL, Corsini EM, Antonoff MB, Hofstetter WL, Rajaram R, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ, Sepesi B. Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma. Ann Thorac Surg. 2022 Jan;113(1):200-208. doi: 10.1016/j.athoracsur.2021.04.078. Epub 2021 May 08. PMID: 33971174.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 87 entries